HNF4A and colorectal carcinoma: In line with that, MEDICA analogs were previously reported to suppress proliferation and HNF-4α expression of cultured CRC cells, similarly to that of SiHNF-4α, and to suppress growth of CRC xenograft transplanted in immunocompromised mice [27].